1Institute of Rheumatology, Russian Academy of Medical Science, Russian Federation.
Lupus. 2014 Feb;23(2):213-9. doi: 10.1177/0961203313512881. Epub 2013 Nov 19.
We assessed the prevalence and incidence of Systemic Lupus Erythematosus (SLE) in 2010 in adults from four cities in Russia, Kazakhstan and Ukraine. Individuals with SLE were identified retrospectively from the medical records of specialized centers. Prevalent SLE patients were nondeceased city residents, diagnosed prior to December 31, 2010; incident patients were residents newly diagnosed between January 1 and December 31, 2010. Population size was obtained from official census data. The observed prevalence rates (per 100,000, 95% CI) were 9.0 (7.1-11.2) in Kursk and Yaroslavl, Russian Federation; 20.6 (15.4-27.0) in Semey, Kazakhstan; and 14.9 (10.9-19.9) in Vinnitsa, Ukraine. The cumulative incidence rates (per 100,000, 95% CI) were 1.4 (0.7-2.4); 1.6 (0.4-4.1) and 0.3 (0.0-1.8), correspondingly. All rates were higher among females compared to males, and incidence peaked in the population aged 25-44. These rates appear slightly lower than those reported from Western Europe and the USA. This could be because of study design (case-ascertainment), local health care practices or true differences in disease risk. Case age and sex distribution was similar to the known epidemiology of SLE. The rates were highest in Kazakhstan, likely because of a predominantly ethnic Asian population.
我们评估了 2010 年俄罗斯、哈萨克斯坦和乌克兰四个城市成年人中系统性红斑狼疮(SLE)的患病率和发病率。通过专门中心的病历记录,回顾性地确定了 SLE 患者。现患 SLE 患者为非死亡城市居民,于 2010 年 12 月 31 日前确诊;新发患者为 2010 年 1 月 1 日至 12 月 31 日期间新确诊的居民。人口规模来自官方人口普查数据。观察到的患病率(每 10 万人,95%CI)分别为俄罗斯联邦库尔斯克和雅罗斯拉夫尔 9.0(7.1-11.2);哈萨克斯坦塞米伊 20.6(15.4-27.0);乌克兰文尼察 14.9(10.9-19.9)。累积发病率(每 10 万人,95%CI)分别为 1.4(0.7-2.4);1.6(0.4-4.1)和 0.3(0.0-1.8)。与男性相比,所有这些比率在女性中都更高,而发病率在 25-44 岁人群中达到峰值。这些比率似乎略低于来自西欧和美国的报告。这可能是由于研究设计(病例发现)、当地医疗保健实践或疾病风险的真实差异。病例年龄和性别分布与已知的 SLE 流行病学相似。哈萨克斯坦的比率最高,可能是因为其主要是亚洲人种。